SCHEMBL35632

SCHEMBL35632

c1ccc2nc3ncncc3nc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.54
MAPT P10636 4/20 0.48
PIK3CG P48736 1/20 0.47
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 3/20 0.39
GLA P06280 2/20 0.39
GAA P10253 2/20 0.39
NQO2 P16083 3/20 0.39
GPR3 P46089 1/20 0.39
PDE10A Q9Y233 1/20 0.38
METAP2 P50579 1/20 0.38
METAP1 P53582 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30124132 1.00 EGFR (0.54) EGFRMAPTPIK3CGPIK3CDPIK3CA
SCHEMBL3292267 0.86 PIK3CG (0.47) EGFRPIK3CGPIK3CDPIK3CAALDH1A1
SCHEMBL31214569 0.86 NQO2 (0.50) EGFRMAPTPIK3CGPIK3CDPIK3CA
SCHEMBL1378685 0.84 PIK3CG (0.46) EGFRPIK3CGALDH1A1METAP2METAP1
SCHEMBL2049528 0.83 EGFR (0.45) EGFRMAPTPIK3CGPIK3CDPIK3CA
SCHEMBL10353335 0.82 PIK3CG (0.44) EGFRMAPTPIK3CGPIK3CDPIK3CA
SCHEMBL22589760 0.80 PLAUR (0.47) EGFRPIK3CGALDH1A1KDM4EHPGD
SCHEMBL4445369 0.78 LMNA (0.60) EGFRMAPTPIK3CGPIK3CDPIK3CA
SCHEMBL3536096 0.76 PIK3CG (0.67) EGFRPIK3CGALDH1A1KDM4EHPGD
SCHEMBL30611771 0.76 PIK3CG (0.41) EGFRPIK3CGMETAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115572258-A C 2 Preparation method of axial chiral biquinoline framework compound 中国科学院成都有机化学有限公司 2023-01-06 CN claimed
CN-115403523-A Biquinoline-aryl phenol framework compound with axial chirality and preparation method and application thereof 中国科学院成都有机化学有限公司 2022-11-29 CN claimed
CN-115403522-A Biphenyl quinoline skeleton compound with C2 axis chirality, chiral isomer thereof, preparation method and application thereof 中国科学院成都有机化学有限公司 2022-11-29 CN claimed
CN-108676007-B Radionuclide-labeled benzopteridine derivative and preparation method and application thereof 厦门大学 2020-06-26 CN claimed
EP-1719200-B1 HIGH-PERFORMANCE MEMBRANE ELECTRODE UNIT AND THE USE THEREOF IN FUEL CELLS BASF FUEL CELL RES GMBH (DE) 2017-08-30 EP claimed
EP-2336315-B1 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION AS (DK) 2017-07-19 EP claimed
EP-2336315-A2 Enzymatic encoding methods for efficient synthesis of large libraries Nuevolution A/S (DK) 2011-06-22 EP claimed
US-20080194821-A1 Light Emitting Compound for Electroluminescent Applications TECHNISCHE UNIVERSITAET BRAUNCHWEIG (DE) 2008-08-14 US claimed
EP-1883687-A1 LIGHT EMITTING COMPOUND FOR ELECTROLUMINESCENT APPLICATIONS Technische Universität Braunschweig (DE) 2008-02-06 EP claimed
WO-2006119800-A1 LIGHT EMITTING COMPOUND FOR ELECTROLUMINESCENT APPLICATIONS TECHNISCHE UNIVERSITÄT BRAUNSCHWEIG (DE) 2006-11-16 WO claimed
EP-0579835-A1 WAVELENGTH CONVERSION MATERIAL FOR AGRICULTURE NIPPON SODA CO., LTD. (JP) 1994-01-26 EP claimed
JP-6040817-A None JP disclosed
US-20240124405-A1 REDOX-ACTIVE COMPOUNDS AND USES THEREOF CMBLU PROJECKT AG (DE) 2024-04-18 US disclosed
US-11952457-B2 Bioabsorbable resin for additive manufacturing with non-cytotoxic photoinitiator CARBON, INC. (US) 2024-04-09 US disclosed
US-20240065990-A1 METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID BELLUS HEALTH INC (CA) 2024-02-29 US disclosed
EP-0383759-A4 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS 1993-03-17 EP disclosed
US-5066655-A Inhibiting adenylate cyclase WHITBY RESEARCH, INC. (US) 1991-11-19 US disclosed
US-4959212-A ENZYMES AND COENZYMES STANCESCO ALEXANDRA (US) 1990-09-25 US disclosed
EP-0383759-A1 N6 SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS Whitby Research Incorporated (US) 1990-08-29 EP disclosed
WO-1988008303-A1 N6-SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS NELSON RESEARCH AND DEVELOPMENT COMPANY (US) 1988-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194821-A1 Light Emitting Compound for Electroluminescent Applications NR2E3, DRD3, OCIAD2 EGFR 185/4885MAPT 1933/4885PIK3CG 4593/4885
US-20240065990-A1 METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID APP, PSEN1, PSEN2 EGFR 1419/4885MAPT 22/4885PIK3CG 1252/4885
US-20240124405-A1 REDOX-ACTIVE COMPOUNDS AND USES THEREOF NOX4, NQO1, GPX1 EGFR 4620/4885MAPT 1567/4885PIK3CG 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.